Dogwood Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Prepaid Expenses and Other Current Assets

3 Months Ended

Mar. 31, 2023

3	Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:


	March 31,		December 31,
	2023		2022
Prepaid insurance	$	878,702	$	1,165,634
Prepaid drug purchases		184,566		—
Prepaid clinical research costs		63,900		154,510
Prepaid services		6,992		11,329
Other miscellaneous current assets		53,915		7,291
	$	1,188,075	$	1,338,764